Doç. Dr. Goncagül Babuna Kobaner

• Psoriasis 5 publications
  Source: OpenAlex / PubMed MeSHView publications
• Dermatitis, Allergic Contact 5 publications
• Skin Neoplasms 3 publications
• Pemphigus 2 publications
• Carcinoma, Squamous Cell 2 publications
• Dermatitis, Occupational 2 publications
• Facial Dermatoses 2 publications
• Hand Dermatoses 2 publications
• Drug Eruptions 2 publications

Experience

• 2026Acıbadem Sağlık Grubuacibadem.com.tr

Education

• 2011İstanbul Üniversitesi İstanbul Tıp Fakültesi, Deri ve Zührevi Hastalıkları, Uzmanlıkacibadem.com.tr
• 2003Marmara Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

• SpecialtyDermatology and Venereologyacibadem.com.trFrom source
• Department name at the sourceDeri Hastalıkları - Dermatoloji (Cildiye)acibadem.com.trFrom source
• InstitutionAcıbadem Maslak Hastanesiacibadem.com.trFrom source
• Area of workPsoriasisExtracted from 5 publications · Model version —From source
• Publications25 publicationsEurope PMC, OpenAlexFrom source
• ORCID0000-0002-0985-5027ORCIDFrom source
• Last synchronised4 November 2026 21:19https://www.acibadem.com.tr/doktor/goncagul-babuna-kobaner/acibadem.com.tr

1. Tobramycin and antiglaucoma agents as increasing culprits of periorbital allergic contact dermatitis from topical ophthalmic medications: A 24-year study from Turkey

   Contact dermatitis, 2023

   DOI 10.1111/cod.14309 PMID 36994896 5 citations (Europe PMC) Open-access full textSource: Europe PMC

2. Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature

   The Australasian journal of dermatology, 2023

   DOI 10.1111/ajd.13986 PMID 36745433 11 citations (Europe PMC) Open-access full textSource: Europe PMC

3. Sorbitan sesquioleate: a rare contact allergen that is also an important indicator of allergic contact dermatitis from crossreacting compounds as well as for false‐positive fragrance allergy

   Clinical and Experimental Dermatology, 2022

   DOI 10.1111/ced.15158 PMID 35245949 5 citations (OpenAlex) Source: OpenAlex

4. Recalcitrant vegetative and nodular scalp lesions on the vertex in pemphigus patients: an immunocompromised district?

   Anais Brasileiros de Dermatologia, 2022

   DOI 10.1016/j.abd.2022.01.007 PMID 36319513 2 citations (OpenAlex) Open-access full textSource: OpenAlex

5. Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey

   Dermatologic therapy, 2021

   DOI 10.1111/dth.15042 PMID 34161621 3 citations (Europe PMC) Open-access full textSource: Europe PMC

6. Secukinumab and acitretin as a combination therapy for three clinical forms of severe psoriasis in multi-drug refractory patients: A case series of high efficacy and safety profile

   Dermatologic therapy, 2021

   DOI 10.1111/dth.14704 PMID 33368934 10 citations (Europe PMC) Open-access full textSource: Europe PMC

7. mRNA Expression Levels of NKp30, NKp46, NKG2D, Perforin and Granzyme in the Behçet’s Disease

   Turkish Journal of Immunology, 2021

   DOI 10.5222/tji.2021.03521 Open-access full textSource: OpenAlex

8. Comparison of three different dose regimens of methylprednisolone as initial therapy for pemphigus vulgaris of moderate severity: A single-center retrospective study from Turkey

   The Australasian journal of dermatology, 2021

   DOI 10.1111/ajd.13560 PMID 33660847 2 citations (Europe PMC) Source: Europe PMC

9. Methylchloroisothiazolinone/methylisothiazolinone and methylisothiazolinone contact allergy: A 24-year, single-center, retrospective cohort study from Turkey

   Contact dermatitis, 2021

   DOI 10.1111/cod.13656 PMID 32691417 14 citations (Europe PMC) Source: Europe PMC

10. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease

    Immunology Letters, 2021

    DOI 10.1016/j.imlet.2021.04.008 PMID 33901541 18 citations (OpenAlex) Source: OpenAlex